STOCK TITAN

Digicann Ventures Inc. Stock Price, News & Analysis

AGFAF OTC

Welcome to our dedicated page for Digicann Ventures news (Ticker: AGFAF), a resource for investors and traders seeking the latest updates and insights on Digicann Ventures stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Digicann Ventures's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Digicann Ventures's position in the market.

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-22.42%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
30.04%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.56%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-27.8%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-28.57%
Tags
-
Rhea-AI Summary

Agra Ventures Ltd. (CSE: AGRA, OTCPK: AGFAF) has announced the issuance of 3,079,774 common shares at approximately $0.05 per share as part of a loan interest payment from December 2020. This action is pending final acceptance from the Canadian Securities Exchange and is subject to a four-month and one-day hold period. The company is focused on the cannabis industry, primarily through its 70% ownership of Boundary Bay Cannabis in Canada and its wholly owned subsidiary, Farmako GmbH, which aims to be a leading distributor of medical cannabis in Europe. Agra Ventures possesses a diversified asset portfolio, enhancing its position in the evolving cannabis market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15.38%
Tags
none
-
Rhea-AI Summary

Agra Ventures Ltd. (CSE: AGRA, OTC: AGFAF) has appointed Nick Kuzyk as its permanent CEO and Director effective March 1, 2023. This decision follows Kuzyk's successful tenure as Interim CEO over the past six months. The Board expressed confidence in his ability to create value and navigate the company's opportunities in the cannabis sector. Kuzyk brings over 20 years of experience in business development and corporate finance within the cannabis industry, having previously served as Chief Strategy Officer at High Tide Inc. Agra Ventures focuses on cannabis cultivation and distribution, both in Canada and Europe.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management
Rhea-AI Summary

Agra Ventures Ltd. (CSE: AGRA, OTC: AGFAF) has approved the issuance of 2,856,449 common shares at approximately $0.05 per share. This issuance is intended to cover part of the quarterly interest on a loan from December 2020. The shares will be subject to a hold period of four months and one day. Agra Ventures focuses on the international cannabis industry, with significant operations in Canada through Boundary Bay Cannabis and a presence in Europe via Farmako GmbH, which is engaged in medical cannabis distribution.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5%
Tags
none

FAQ

What is the current stock price of Digicann Ventures (AGFAF)?

The current stock price of Digicann Ventures (AGFAF) is $0.0011 as of January 12, 2026.

What is the market cap of Digicann Ventures (AGFAF)?

The market cap of Digicann Ventures (AGFAF) is approximately 357.4K.
Digicann Ventures Inc.

OTC:AGFAF

AGFAF Rankings

AGFAF Stock Data

357.36k
22.35M
0.77%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Canada
Vancouver

AGFAF RSS Feed